Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Visible light Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113754631B reveals a mild, regioselective method for heteroaryl indoles using visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113956208A reveals a metal-free, Eosin Y-catalyzed arylation method offering cost reduction in pharmaceutical intermediate manufacturing and scalable green chemistry solutions.
Patent CN108117507B details a green visible-light method for azaspirocyclohexadienone synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and high purity.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN118344244A enables visible light catalyzed deuteration using D2O. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates.
Patent CN108947880B reveals a metal-free visible light method for thiocarbamates. Eliminate toxic phosgene, reduce costs, and ensure supply continuity with our advanced green chemistry solutions.
Novel visible light method reduces metal waste. Enhances supply chain stability for high-purity pharmaceutical intermediates. Cost-effective scalable production.
Patent CN107417566A enables ligand-free N-aryl hydrazone synthesis using BODIPY photocatalysts. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel visible-light method for iodo-bicyclo[1.1.1]pentane derivatives. Cost-effective, catalyst-free process ensuring high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN115448816A reveals a mild, visible-light driven route for beta-fluoroalkenyl alcohols, offering safer manufacturing and cost reduction for pharma intermediates.
Patent CN116178254B reveals metal-free photocatalytic route for 2-trifluoromethylquinoline. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates globally.
Patent CN116462636B reveals green visible light synthesis for quinoxalinone derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112321553A reveals a catalyst-free visible light method for 3-difluoromethyl coumarins, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112194608A details a visible-light promoted synthesis method offering high yields and mild conditions for pharmaceutical intermediates.
Patent CN113248422A details a visible-light catalyzed method for chiral azaarenes, offering green synthesis and high enantioselectivity for pharmaceutical intermediates.
Novel photocatalytic route for dihydronaphthalene derivatives offering mild conditions and high yields for pharmaceutical intermediates.
Patent CN112898202A details a mild visible-light photocatalytic method for synthesizing heterocyclyl cyclopropane compounds, offering significant advantages for pharmaceutical intermediate manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel metal-free visible light catalytic method for 1,2,3,4-tetrahydronaphthalene intermediates. Offers high atom utilization and mild conditions for pharma manufacturing.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.